Rates of Stent Thrombosis in Bare-Metal Versus Drug-Eluting Stents (from a Large Australian Multicenter Registry)

American Journal of Cardiology

Volumn 101, Issue 12, 2008, Pages 1716-1722

  Yan, Bryan P ^a   Duffy, Stephen J ^b   Clark, David J ^c   Lefkovits, Jeffery ^d   Warren, Roderic ^d   Gurvitch, Ronen ^d   Lew, Robert ^e   Sebastian, Martin ^f   Brennan, Angela ^g   Andrianopoulos, Nick ^g   Reid, Christopher M ^g   Ajani, Andrew E ^d,g,h  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b ALFRED HOSPITAL   (Australia)

^c AUSTIN HOSPITAL   (Australia)

^d ROYAL MELBOURNE HOSPITAL   (Australia)

^e FRANKSTON HOSPITAL   (Australia)

^f GEELONG HOSPITAL   (Australia)

^g NATIONAL HEALTH AND MEDICAL RESEARCH COUNCIL   (Australia)

^h UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CLOPIDOGREL;

ACUTE CORONARY SYNDROME; ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; AUSTRALIA; CARDIOVASCULAR RISK; CONFIDENCE INTERVAL; CORONARY STENT; DIABETES MELLITUS; DRUG ELUTING STENT; FEMALE; HEART DEATH; HEART INFARCTION; HUMAN; IMPLANT; INCIDENCE; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MEDICAL RESEARCH; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; REGISTER; RESTENOSIS; ST SEGMENT; THROMBOSIS;

AGED; COATED MATERIALS, BIOCOMPATIBLE; CONFIDENCE INTERVALS; CORONARY DISEASE; CORONARY RESTENOSIS; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; METALS; MIDDLE AGED; MYOCARDIAL REVASCULARIZATION; ODDS RATIO; PROGNOSIS; PROSTHESIS FAILURE; REGISTRIES; RISK FACTORS; STENTS; SURVIVAL RATE; TIME FACTORS; VICTORIA;

EID: 44649098129     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2008.02.058     Document Type: Article

References (21)

1. Iakovou I., Schmidt T., Bonizzoni E., Ge L., Sangiorgi G.M., Stankovic G., Airoldi F., Chieffo A., Montorfano M., Carlino M., et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 293 (2005) 2126-2130
2. Holmes Jr. D.R., Kereiakes D.J., Laskey W.K., Colombo A., Ellis S.G., Henry T.D., Popma J.J., Serruys P.W., Kimura T., Williams D.O., Windecker S., and Krucoff M.W. Thrombosis and drug-eluting stents: an objective appraisal. J Am Coll Cardiol 50 (2007) 109-118
3. Lagerqvist B., James S.K., Stenestrand U., Lindback J., Nilsson T., Wallentin L., and SCAAR Study Group. Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden. N Engl J Med 356 (2007) 1009-1019
4. Daemen J., Wenaweser P., Tsuchida K., Abrecht L., Vaina S., Morger C., Kukreja N., Juni P., Sianos G., Hellige G., et al. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study. Lancet 369 (2007) 667-678
5. Tu J.V., Bowen J., Chiu M., Ko D.T., Austin P.C., He Y., Hopkins R., Tarride J.E., Blackhouse G., Lazzam C., Cohen E.A., and Goeree R. Effectiveness and safety of drug-eluting stents in Ontario. N Engl J Med 357 (2007) 1393-1402
6. Ajani A.E., Szto G., Duffy S.J., Eccleston D., Clark D.J., Lefkovits J., Chew D.P., Warren R., Black A., New G., and Melbourne Interventional Group Investigators. The foundation and launch of the Melbourne Interventional Group: a collaborative interventional cardiology project. Heart Lung Circ 15 (2006) 44-47
7. Yan B.P., Ajani A.E., Duffy S.J., New G., Horrigan M., Szto G., Walton A., Eccleston D., Lefkovits J., Black A., et al. Use of drug-eluting stents in Victorian public hospitals. Med J Aust 185 (2006) 363-367
8. Smith Jr. S.C., Feldman T.E., Hirshfeld Jr. J.W., Jacobs A.K., Kern M.J., King III S.B., Morrison D.A., O'Neill W.W., Schaff H.V., Whitlow P.L., and American College of Cardiology/American Heart Association Task Force on Practice Guidelines; American College of Cardiology/American Heart Association/Society for Cardiovascular Angiography and Interventions Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention. ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention-summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention). Circulation 113 (2006) 156-175
9. Cutlip D.E., Windecker S., Mehran R., Boam A., Cohen D.J., van Es G.A., Steg P.G., Morel M.A., Mauri L., Vranckx P., and Academic Research Consortium. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation 115 (2007) 2344-2351
10. Jensen L.O., Maeng M., Kaltoft A., Thayssen P., Hansen H.H., Bottcher M., Lassen J.F., Krussel L.R., Rasmussen K., Hansen K.N., et al. Stent thrombosis, myocardial infarction, and death after drug-eluting and bare-metal stent coronary interventions. J Am Coll Cardiol 50 (2007) 463-470
11. Urban P., Gershlick A.H., Guagliumi G., Guyon P., Lotan C., Schofer J., Seth A., Sousa J.E., Wijns W., Berge C., Deme M., Stoll H.P., and e-Cypher Investigators. Safety of coronary sirolimus-eluting stents in daily clinical practice: one-year follow-up of the e-Cypher registry. Circulation 113 (2006) 1434-1441
12. Williams D.O., Abbott J.D., Kip K.E., and DEScover Investigators. Outcomes of 6906 patients undergoing percutaneous coronary intervention in the era of drug-eluting stents: report of the DEScover Registry. Circulation 114 (2006) 2154-2162
13. Stettler C., Wandel S., Allemann S., Kastrati A., Morice M.C., Schomig A., Pfisterer M.E., Stone G.W., Leon M.B., de Lezo J.S., et al. Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis. Lancet 370 (2007) 937-948
14. Machecourt J., Danchin N., Lablanche J.M., Fauvel J.M., Bonnet J.L., Marliere S., Foote A., Quesada J.L., Eltchaninoff H., Vanzetto G., and EVASTENT Investigators. Risk factors for stent thrombosis after implantation of sirolimus-eluting stents in diabetic and nondiabetic patients: the EVASTENT Matched-Cohort Registry. J Am Coll Cardiol 50 (2007) 501-508
15. Kuchulakanti P.K., Chu W.W., Torguson R., Ohlmann P., Rha S.W., Clavijo L.C., Kim S.W., Bui A., Gevorkian N., Xue Z., et al. Correlates and long-term outcomes of angiographically proven stent thrombosis with sirolimus- and paclitaxel-eluting stents. Circulation 113 (2006) 1108-1113
16. Chen M.S., John J.M., Chew D.P., Lee D.S., Ellis S.G., and Bhatt D.L. Bare metal stent restenosis is not a benign clinical entity. Am Heart J 151 (2006) 1260-1264
17. Nayak A.K., Kawamura A., Nesto R.W., Davis G., Jarbeau J., Pyne C.T., Gossman D.E., Piemonte T.C., Riskalla N., and Chauhan M.S. Myocardial infarction as a presentation of clinical in-stent restenosis. Circ J 70 (2006) 1026-1029
18. Grines C.L., Bonow R.O., Casey DE Jr., Gardner T.J., Lockhart P.B., Moliterno D.J., O'Gara P., Whitlow P., and American Heart Association; American College of Cardiology; Society for Cardiovascular Angiography and Interventions; American College of Surgeons; American Dental Association; American College of Physicians. Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians. Circulation 115 (2007) 813-818
19. Bhatt D.L., Fox K.A., Hacke W., Berger P.B., Black H.R., Boden W.E., Cacoub P., Cohen E.A., Creager M.A., Easton J.D., and CHARISMA Investigators. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med 354 (2006) 1706-1717
20. Eisenstein E.L., Anstrom K.J., Kong D.F., Shaw L.K., Tuttle R.H., Mark D.B., Kramer J.M., Harrington R.A., Matchar D.B., Kandzari D.E., et al. Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation. JAMA 297 (2007) 159-168
21. Spertus J.A., Kettelkamp R., Vance C., Decker C., Jones P.G., Rumsfeld J.S., Messenger J.C., Khanal S., Peterson E.D., Bach R.G., Krumholz H.M., and Cohen D.J. Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement: results from the PREMIER registry. Circulation 113 (2006) 2803-2809